TWO · 4139.TWO
Ma Kuang Healthcare Holding Limited
NT$41.95-NT$1.55 (-3.56%)
Ma Kuang Healthcare Holding Limited’s quoted price sits in the upper half of its reported 52-week range, 7.8% below the high.
Loading market information…
TWO · 6493.TWO · TWD
Stock price, dividends
Quote as of Oct 30, 2026, 06:45 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Ttbio Corp.’s quoted price sits in the lower half of its reported 52-week range, 48.17% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Ttbio Corp.’s forward annual dividend is NT$0.20 per share, paid annual. The forward yield is 0.64% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
Ttbio Corp. specializes in the development, distribution, and after-sales support of medical devices under its proprietary TTBIO brand, serving both the Taiwanese domestic market and a global clientele. Its product offerings include a range of high-speed and low-speed dental handpieces, alongside essential dental spare components, service rotors, maintenance systems, and advanced electric handpiece solutions. Beyond its core medical device portfolio, Ttbio is also a key supplier of high-precision machined parts and custom components. These are engineered to cater to diverse sectors such as automotive, aerospace, security, and computing hardware, in addition to providing parts for general industrial maintenance and specialized custom projects. Established in 2012, Ttbio Corp. maintains its headquarters in Taichung, Taiwan.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:27 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$41.95-NT$1.55 (-3.56%)
Ma Kuang Healthcare Holding Limited’s quoted price sits in the upper half of its reported 52-week range, 7.8% below the high.
NT$71.70+NT$0.20 (+0.28%)
Puriblood Medical Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 23.48% below the high.
NT$30.15NT$0.00 (0.0%)
Concord Medical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.75% below the high.
NT$30.60-NT$0.05 (-0.16%)
Level Biotechnology Inc.’s quoted price sits in the lower half of its reported 52-week range, 11.82% below the high.
NT$15.40-NT$0.65 (-4.05%)
AmCad BioMed Corporation’s quoted price sits in the upper half of its reported 52-week range, 18.3% below the high.
NT$13.95-NT$0.05 (-0.36%)
LAUNXP Biomedical Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 45.19% below the high.
NT$24.00NT$0.00 (0.0%)
Wiltrom Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 20.66% below the high.
NT$6.35-NT$0.34 (-5.08%)
PlexBio Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 59.81% below the high.
